We have located links that may give you full text access.
Intranasal Leptin Relieves Sleep Disordered Breathing in Mice with Diet Induced Obesity.
American Journal of Respiratory and Critical Care Medicine 2018 October 13
RATIONALE: Leptin treats upper airway obstruction and alveolar hypoventilation in leptin deficient ob/ob mice. However, obese humans and mice with diet-induced obesity are resistant to leptin due to poor permeability of the blood-brain barrier. We propose that intranasal leptin will bypass leptin resistance and treat sleep disordered breathing in obesity.
OBJECTIVES: To assess if intranasal leptin can treat obesity hypoventilation and upper airway obstruction during sleep in mice with diet-induced obesity.
METHODS: Male C57BL/6J mice were fed with a high fat diet for 16 weeks. A single dose of leptin (0.4 mg/kg) or bovine serum albumin (vehicle) were administered intranasally or intraperitoneally followed by either sleep studies (n=10) or energy expenditure measurements (n=10). A subset of mice was treated with leptin daily for 14 days for metabolic outcomes (n=20). In a separate experiment, retrograde viral tracers were used to examine connections between leptin receptors and respiratory motoneurons.
MEASUREMENTS AND MAIN RESULTS: Acute intranasal but not intraperitoneal leptin decreased the number of oxygen desaturation events in REM sleep, and increased ventilation in NREM and REM sleep, independently of metabolic effects. Chronic intranasal leptin decreased food intake and body weight, while intraperitoneal leptin had no effect. Intranasal leptin induced signal transducer and activator of transcription 3 phosphorylation in hypothalamic and medullary centers, whereas intraperitoneal leptin had no effect. Leptin receptor positive cells were synaptically connected to respiratory motoneurons.
CONCLUSIONS: In mice with diet-induced obesity, intranasal leptin bypassed leptin resistance and significantly attenuated sleep-disordered breathing, independently of body weight.
OBJECTIVES: To assess if intranasal leptin can treat obesity hypoventilation and upper airway obstruction during sleep in mice with diet-induced obesity.
METHODS: Male C57BL/6J mice were fed with a high fat diet for 16 weeks. A single dose of leptin (0.4 mg/kg) or bovine serum albumin (vehicle) were administered intranasally or intraperitoneally followed by either sleep studies (n=10) or energy expenditure measurements (n=10). A subset of mice was treated with leptin daily for 14 days for metabolic outcomes (n=20). In a separate experiment, retrograde viral tracers were used to examine connections between leptin receptors and respiratory motoneurons.
MEASUREMENTS AND MAIN RESULTS: Acute intranasal but not intraperitoneal leptin decreased the number of oxygen desaturation events in REM sleep, and increased ventilation in NREM and REM sleep, independently of metabolic effects. Chronic intranasal leptin decreased food intake and body weight, while intraperitoneal leptin had no effect. Intranasal leptin induced signal transducer and activator of transcription 3 phosphorylation in hypothalamic and medullary centers, whereas intraperitoneal leptin had no effect. Leptin receptor positive cells were synaptically connected to respiratory motoneurons.
CONCLUSIONS: In mice with diet-induced obesity, intranasal leptin bypassed leptin resistance and significantly attenuated sleep-disordered breathing, independently of body weight.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app